AstraZeneca rejoins leading U.S. drug lobby group after two-year absence
(Reuters) -AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical...
(Reuters) -AstraZeneca has rejoined the main U.S. drug lobby group, roughly two years after leaving it, the Pharmaceutical...
-- Elliott Investment Management has raised its stake in BP PLC ADR (NYSE:BP) to just over 5%, intensifying its...
(Reuters) -Tesla short sellers are up an estimated $11.5 billion for the year-to-date and positioning is bearish going into the...
By Allison Lampert (Reuters) -Spirit AeroSystems’ chief engineer Sean Black will lead the supplier’s site in Wichita, Kansas,...
(Reuters) -Bitcoin, the world’s largest cryptocurrency, rose 5.01% to $91,713.49, after earlier breaking through the $90,000 for...
U.Today - Bloomberg’s senior ETF analyst Eric Balchunas has drawn the community’s attention to the fact that recently...
-- Air Canada (TSX:AC)’s President and Chief Executive Officer, Michael Rousseau, has announced a realignment of...
-- Amazon (NASDAQ:AMZN) has announced the general availability of its Bedrock Intelligent Prompt Routing. This tool,...
-- Apple Inc (NASDAQ:AAPL).’s newly appointed Siri engineering chief, Mike Rockwell, is undertaking a significant...
By Shadia Nasralla (Reuters) -Activist investor Elliott Management has urged BP (NYSE:BP) to boost its free cash flow to $20...